Search Results 211-220 of 16847 for Goserelin

  1. Leuprolide (intradermal route, intramuscular route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Leuprolide injection is a synthetic (man-made) hormone that is similar to a natural hormone that is produced in the brain. It is used to treat a number of ...

  2. Clinical trials - Oncology (Medical)

    Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.

  3. Cancer Physicians - Medical Professionals - Mayo Clinic

    Find Award Winning Physicians that treat Cancer at your nearest Mayo Clinic location. Learn about the conditions they treat and procedures performed.

  4. Neurology - Clinical trials - Mayo Clinic

    The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

  5. Clinical trials - Oncology (Medical)

    The purpose of this study is to find the maximum tolerated dose of iberdomide for patients newly diagnosed with multiple myeloma, and to determine response ...

  6. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  7. Peginesatide (injection route) - Side effects & dosage - Mayo Clinic

    Peginesatide injection is used to treat anemia in patients with chronic kidney disease (CKD) who are on dialysis. This medicine was available only with your ...

  8. Gepotidacin (oral route) - Side effects & dosage - Mayo Clinic

    Gepotidacin is used to treat uncomplicated urinary tract infections (uUTI) and a sexually transmitted disease called uncomplicated urogenital gonorrhea.

  9. Lifileucel (intravenous route) - Side effects & uses - Mayo Clinic

    Lifileucel injection is used to treat melanoma (skin cancer) that has spread or cannot be removed by surgery. This medicine is given to patients who have ...

  10. Clinical trials - Oncology (Medical)

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...